Evaluation of the Inflammation-based Index as a Predictive Marker of Clinical and Radiological Response in Patients Treated With Lu-177 Oxodotreotide for Intestinal Neuroendocrine Tumour
Evaluation of the Inflammation-based Index as a Predictive Marker of Clinical and Radiological Response in Patients Treated With Lu-177 Oxodotreotide for Intestinal Neuroendocrine Tumour
Recruiting · NCT06876532 · Registry updated 2026-07-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluation of the Inflammation-based Index as a Predictive Marker of Clinical and Radiological Response in Patients Treated With Lu-177 Oxodotreotide for Intestinal Neuroendocrine Tumour | Intestinal Neuroendocrine Tumor | Recruiting | Not applicable | 2026-07-13 | NCT06876532 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Institut Claudius Regaud | 39 |
10 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Centre François Baclesse | Caen | France | 39 |
| Chu de Bordeaux | Bordeaux | France | 66 |
| CHU de Lille | Lille | France | 38 |
| CHU de Lyon | Lyon | France | 10 |
| CHU de Poitiers | Poitiers | France | 40 |
| CHU Hôtel Dieu | Nantes | France | 3 |
| Hôpital La Timone | Marseille | France | 5 |
| Institut de Cancérologie de l'Ouest | Angers | France | 11 |
| Institut de Cancérologie de Montpellier | Montpellier | France | 4 |
| IUCT-O | Toulouse | France | 12 |